Despite bitcoin (BTC) falling back below $30,000 as spot ETF application and favorable XRP ruling optimism fade, the frenzy in meme coin markets remains...
ImmunoGen (NASDAQ:IMGN) is a large biopharmaceutical company (market cap of $4.8 billion) that uses antibody-drug conjugate (‘ADC’) technology to develop novel therapeutics against cancer....